Will Canopy Growth Corp (TSX:WEED) Hit $1 Billion in Sales Next Year?

Some are predicting that Canopy Growth Corp (TSX:WEED)(NYSE:CGC) will hit $1 billion in sales for 2019

| More on:

Remember the Canopy Growth Corp (TSX:WEED)(NYSE:CGC)/Constellation Brands (NYSE:STZ) acquisition?

Last year, it was one of the biggest stories in the Canadian markets. After months of legalization hype, Constellation announced in August that it would be acquiring a huge $5 billion stake in Canopy, bringing its total ownership to 35%. The acquisition began a massive rally in weed stocks that raised not only Canopy, but also most of its competitors.

Since last fall, the Constellation deal has seen few new developments. But the company’s CEO recently spoke out in a rare public comment that may reveal why Constellation was willing to pay so much in the 2018 deal.

Constellation CEO says Canopy headed to $1 billion in annual revenue

In a recent conference call, Constellation Brands CEO Bill Newlands claimed that Canopy Growth would hit $1 billion in revenue by 2020. This was not the first time that Newlands made this claim. However, it was the first time he was able to back it up with clear data. Using Canopy’s $83 million in Q3 revenue and 282% net revenue growth rate, he concluded that a “run rate” of $1 billion was within striking distance.

Why $1 billion is such a crucial benchmark

You see, $1 billion in revenue is a crucial milestone for Constellation Brands for one simple reason: its stake in Canopy is massive. Not only did it invest $5 billion in Canopy stock last year, but it took a smaller stake a few months prior to that. This is a company with a huge chunk of coin riding on Canada’s largest weed stock. A valuation of $5 billion implies that Canopy will be worth that much from its discounted future cash flows–notwithstanding the possibility of Constellation simply dumping its Canopy shares at a high price.

For Canopy to be worth that much over, say, a 50-year period, it needs to generate $100 million a year in net income for 50 years. Given the typical profit margins in the cannabis space, the company would therefore have to start doing well over a billion in sales to be worth what Constellation paid for it.

Canopy’s revenue growth

It’s definitely within the realm of possibility that Canopy could hit $1 billion in revenue this year or the next. Judging by last quarter’s sales, the company could earn up to $332 million this year. If last quarter’s net revenue growth rate stays steady into next year at 280%, then that $332 million could rise to $929 million next year. That’s just a hair short of a billion.

Also, if Canopy sees accelerating revenue growth this year, it’s not impossible that the company could even hit the $1 billion mark before 2019 is out. However, it would require significant acceleration, as Canopy’s quarter by quarter revenue growth in 2018 was not amazing. In Q2 (which corresponds to Q3 of the 2018 calendar year), for example, revenue was actually down from Q1, at $23 million vs $25 million.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »